06:24 AM EST, 02/12/2026 (MT Newswires) -- West Pharmaceutical Services ( WST ) reported Q4 non-GAAP earnings Thursday of $2.04 per diluted share, up from $1.82 a year earlier.

Analysts polled by FactSet expected $1.83.

Net sales for the quarter ended Dec. 31 were $805 million, up from $748.8 million a year earlier.

Analysts surveyed by FactSet expected $794.9 million.

For Q1, the company expects adjusted EPS of $1.65 to $1.70 on revenue of $770 million to $790 million. Analysts surveyed by FactSet expect $1.65 and $761.3 million, respectively.

West Pharmaceutical said it expects 2026 adjusted EPS of $7.85 to $8.20 on net sales of $3.22 billion to $3.28 billion. Analysts surveyed by FactSet expect $7.80 and $3.24 billion, respectively.

The company's shares were up 5.6% in recent premarket activity.